Two complementary lines of Parkinson’s research emphasized precision—one using computational and sensing strategies to anticipate disease trajectories and treatment sensitivity, and another identifying anatomical metrics that may forecast neuromodulation outcomes. On the neurotechnology side, work reported parameter scaling limits in vagus nerve stimulation across species and humans, underscoring translation bottlenecks when moving from preclinical models to clinical dosing. Separately, imaging-based modeling efforts highlighted how individual brain anatomy can predict response heterogeneity in stimulation-based interventions. Together, the findings point toward more individualized neuromodulation protocols supported by better cross-model mapping and patient-specific targeting markers.